Improving Patient Education for Lymphoma and Leukemia Inpatients

Lymphoma Clinical Trial

Official title:

Improving Patient Education for Newly Diagnosed Lymphoma and Acute Leukemia Inpatients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02642510
• Other study ID #: IRB00073387
• Status: Completed
• Phase: N/A
• First received: December 27, 2015
• Last updated: June 21, 2017
• Start date: June 2014
• Est. completion date: February 20, 2017

Study information

• Verified date: June 2017
• Source: Emory University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the impact of a structured, DVD educational intervention about what to expect during inpatient treatment of a newly diagnosed cancer. The focus of the study will be newly diagnosed lymphoma and acute leukemia patients and their family members. Outcome variables will be the patient and family member's satisfaction with inpatient teaching and anxiety about inpatient treatment.

Description:

The purpose of this study is to evaluate the impact of a structured, DVD educational intervention about what to expect during inpatient treatment of a newly diagnosed cancer. The focus of the study will be newly diagnosed lymphoma and acute leukemia patients and their family members. Outcome variables will be the patient and family member's satisfaction with inpatient teaching and anxiety about inpatient treatment.

The experimental group will watch a DVD educational presentation of information about unit routines and activities; leukemia/lymphoma; treatment modalities and procedures; treatment of side effects; and patient and family members activities of importance to prevent infection and promote well-being during cancer treatment.

Participants in the control group will receive usual educational teaching by their assigned nursing staff.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 78
• Est. completion date: February 20, 2017
• Est. primary completion date: February 20, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

For participants admitted for suspect diagnosis of leukemia or lymphoma:

• Admission to the hematology/leukemia unit (6E) at Emory University Hospital with a suspected or actual new diagnosis of leukemia or lymphoma within the past 24 hours

• English-speaking

• Completed education to at least the 6th grade level

• No significant auditory or visual deficits with corrective devices

• No central nervous system involvement of disease

• Physiologically stable

• Not at end of life

• No alterations in mental status

• Agrees to family member (family member; significant other; friend) participation in study and to selecting the individual who could participate

For Family Members:

• Willing to view DVD and read education booklet

• Selected by patient to participate

• English speaking

• No significant auditory or visual deficits with corrective devices

• No alterations in mental status

• Completed education to at least the 6th grade level

Exclusion Criteria:

• At end of life

• Altered mental status

• Significant auditory or visual deficits with corrective devices

Related Conditions & MeSH terms

• Leukemia
• Lymphoma

Intervention

Other:
• Structured Education DVD + Verbal Teaching
The structured education DVD is a 15-minute DVD presentation of information about unit routines and activities; leukemia/lymphoma; treatment modalities and procedures; treatment of side effects; and participant and family members activities of importance to prevent infection and promote well-being during cancer treatment. Participants will also receive verbal educational teaching by their assigned nursing staff regarding information about leukemia and lymphoma, common treatments, and side effects.
• Verbal Teaching
Participants will receive verbal educational teaching by their assigned nursing staff regarding information about leukemia and lymphoma, common treatments, and side effects.

Locations

Country	Name	City	State
United States	Emory University Hospital	Atlanta	Georgia

Sponsors (1)

Lead Sponsor	Collaborator
Emory University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of Discharge Teaching Scale (QDTS) Score	Overall satisfaction will be measured with the Quality of Discharge Teaching Scale (QDTS).The QDTS is a 24 item survey to evaluate all of the teaching received by patients during their hospitalization prior to discharge. Each item on the survey is rated on a 0 to 10 numeric scale, with 0 representing an item was not addressed and 10 representing an item addressed a great deal. For each aspect of education or information being evaluated, participant are asked to rate the content of the education, as well as the delivery of the content.	Post Educational Teaching (Up to 30 minutes)
Secondary	Visual analog scale (VAS) Score	Participants are instructed to place a horizontal mark across the 100 mm vertical line anchored at one end with the words "No Anxiety" and at the other end "Worst Anxiety Imaginable" at the level of their anxiety about inpatient cancer treatment. Rating of anxiety for the study will be done by having the participant mark their anxiety level on a new, unmarked VAS. Scoring of the VAS is done by measuring in millimeters from the end of the vertical line with the anchor phrases of "no anxiety" to the intersection of the participant's mark on the vertical line. Possible scores on the VAS range from 0 to 100 millimeters with higher scores indicating higher levels of anxiety.	Post Educational Teaching (Up to 30 minutes)